Humana

HUM

Market cap $31.9B

Overview Fund Activity

264.86 USD

-4.53

1.68%

At close Updated Sep 18, 4:00 PM EDT

Pre-market

After hours

264.86

0.00

0%

1 day

-1.68%

5 days

-4.38%

1 month

-7.78%

3 months

8.82%

6 months

-1.82%

Year to date

4.83%

1 year

-15.99%

5 years

-34.22%

10 years

40.97%

About: Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Employees: 65,680

Healthcare Healthcare Plans

0

Funds holding %

of 7,463 funds

0

Analysts bullish %

of 10 analysts

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

47% more call options, than puts

Call options by funds: $2.04B | Put options by funds: $1.39B

0.78% more ownership

Funds ownership: 93.11% [Q1] → 93.89% (+0.78%) [Q2]

4% less repeat investments, than reductions

Existing positions increased: 317 | Existing positions reduced: 329

9% less first-time investments, than exits

New positions opened: 109 | Existing positions closed: 120

3% less funds holding

Funds holding: 892 [Q1] → 868 (-24) [Q2]

7% less capital invested

Capital invested by funds: $29.7B [Q1] → $27.7B (-$2.03B) [Q2]

35% less funds holding in top 10

Funds holding in top 10: 17 [Q1] → 11 (-6) [Q2]

See Fund Rankings

Research analyst outlook

10 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$260

2% downside

Avg. target

$302

14% upside

High target

$344

30% upside

10 analyst ratings

3 positive

30%

7 neutral

70%

0 negative

0%

Bernstein Lance Wilkes	$341	Outperform Maintained	5 Sep 2025
Barclays Andrew Mok	$315	Equal-Weight Maintained	5 Sep 2025
B of A Securities Kevin Fischbeck	$312	Neutral Maintained	2 Sep 2025
RBC Capital Ben Hendrix	$322	Outperform Maintained	21 Aug 2025
Wells Fargo Stephen Baxter	$344	Overweight Maintained	14 Aug 2025
Argus Research David Toung	$282	Hold Reiterated	14 Aug 2025
Morgan Stanley Erin Wright	$277	Equal-Weight Maintained	31 Jul 2025
Piper Sandler Jessica Tassan	$272	Neutral Maintained	31 Jul 2025
Baird Michael Ha	$297	Neutral Maintained	25 Jul 2025
Truist Securities David Macdonald	$260	Hold Maintained	16 Jul 2025

See Analyst Rankings

Financial journalist opinion

Based on 20 articles about HUM published over the past 30 days

Zacks Investment Research

2 HMO Stocks Poised to Thrive Despite Escalating Medical Costs

The Medical-HMO industry benefits from strength in commercial plans, M&A and expected Medicare rate hikes, but rising costs, regulatory shifts and workforce shortages strain margins. CI and HUM are likely to navigate industry storms.

2 HMO Stocks Poised to Thrive Despite Escalating Medical Costs

New Research in a New England Journal of Medicine Publication Finds Patients of Value-Based Care Organizations Have More Frequent and Consistent Primary Care Visits

LOUISVILLE, Ky.--(BUSINESS WIRE)--A new study published in The New England Journal of Medicine Catalyst, conducted by the Humana Healthcare Research team and Massachusetts General Hospital Attending Physician Dr. Suhas Gondi, who completed the research while a resident physician at Harvard Medical School's Brigham and Women's Hospital, finds that patients who receive care from senior-focused primary care organizations that practice value-based care are more likely to regularly use primary care.

New Research in a New England Journal of Medicine Publication Finds Patients of Value-Based Care Organizations Have More Frequent and Consistent Primary Care Visits

The Secret Blue-Chip Rally No One Knows About: 4 Amazing Ideas To Consider

People might be shocked to learn the Mag 7 are not in a bubble. The PEGY ratio of 0.9 to 1.0 confirms Morningstar's fair value estimate. However, you might be even more shocked to discover that value is having an incredible rally this year, with stocks like Realty Income beating the Mag 7. Accelerating EPS growth, combined with falling interest rates (which enhance the profitability of value stocks) and AI-fueled margin expansion, could cause this value rally to persist for years.

The Secret Blue-Chip Rally No One Knows About: 4 Amazing Ideas To Consider

What Moved Markets This Week

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.

What Moved Markets This Week

Zacks Investment Research

Humana Wins TVH Assets in Bankruptcy Sale, But Cut Points Drag Shares

Humana Inc. HUM, through its healthcare services businessCenterWell, has won court approval to acquire the assets of The Villages Health (“TVH”), a well-known medical group in Florida. The deal marks another step in Humana's effort to expand its senior-focused primary care platform and strengthen ties to its Medicare Advantage (MA) membership base.

Humana Wins TVH Assets in Bankruptcy Sale, But Cut Points Drag Shares

Court Approves CenterWell's Winning Bid to Acquire Assets of The Villages Health ("TVH")

ORLANDO, Fla. , Sept. 9, 2025 /PRNewswire/ -- The Villages Health ("TVH"), the trusted healthcare system for The Villages retirement community in Florida, today announced that the United States Bankruptcy Court for the Middle District of Florida (the "Court") approved a winning asset bid for CenterWell Senior Primary Care to acquire TVH's assets as a going concern following the system's filing for Chapter 11 Bankruptcy restructuring in early July 2025.

Court Approves CenterWell's Winning Bid to Acquire Assets of The Villages Health ("TVH")

Zacks Investment Research

Humana (HUM) is a Top-Ranked Momentum Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Humana (HUM) is a Top-Ranked Momentum Stock: Should You Buy?

The Motley Fool

These Were the 5 Top-Performing Stocks in the S&P 500 in August 2025

If you buy a stock that goes up 20% in a year, I'd say you made a good investment. After all, the S&P 500 (^GSPC 0.51%) returns somewhere around 10% annually on average.

These Were the 5 Top-Performing Stocks in the S&P 500 in August 2025

CenterWell Home Health Launching 21st Food Fundraising Drive

LOUISVILLE, Ky.--(BUSINESS WIRE)--CenterWell Home Health launching 21st food fundraising drive.

CenterWell Home Health Launching 21st Food Fundraising Drive

Top 15 High-Growth Dividend Stocks For September 2025

My Top 15 high-growth dividend stocks for September 2025 are collectively 32% undervalued and offer a 1.43% yield with 21.57% five-year dividend growth. The strategy's five-year annualized return is 11.22%, just shy of my 12% target, but it continues to outperform VIG and SPY year-to-date. Rotation in the list brings in DICK'S Sporting Goods, Elevance Health, Intuit, and Marsh & McLennan, replacing stocks that fell below the 12% expected return threshold.

Top 15 High-Growth Dividend Stocks For September 2025

See News Rankings

Charts implemented using Lightweight Charts™